
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Breast malignant, males, children
In situ carcinoma
Apocrine DCIS
Reviewer: Dina Kandil, M.D. (see Reviewers
page)
Revised: 3 November 2012, last major update January 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.
Definition
=========================================================================
● DCIS with cells containing abundant eosinophilic cytoplasm, vesicular nuclei and prominent nucleoli
● Uncommon variant; clinical behavior similar to classic DCIS
Micro description / grading
=========================================================================
● Growth pattern may be solid, cribriform or micropapillary
● Tumor grade is based on nuclear features and presence of comedo-type necrosis
(Hum Pathol 2001;32:487)
● Nuclei are graded 1-3 based on nuclear size, pleomorphism and nucleoli
● Nuclear size (compared to benign apocrine cells) is either small (1-2x), intermediate (3-4x) or large (5x or larger)
● Grade 1 nuclei: low pleomorphism, small/intermediate size, usually single prominent nucleolus
● Grade 2 nuclei: moderate pleomorphism, small/intermediate size, multiple nucleoli; may have occasional large nuclei or multinucleated cells
● Grade 3 nuclei: intermediate/large size, marked pleomorphism, coarse chromatin, irregular nuclear contour, frequently multiple nucleoli
● Necrosis: punctuate or comedo necrosis
● Low-grade: nuclear grade 1 or 2 without necrosis
● High-grade: tumors with grade 3 nuclei and necrosis; similar to high grade nonapocrine DCIS, but with cytoplasmic apocrine features and 10%+ nuclei with single large nucleolus and vesicular chromatin
● Intermediate-grade: cases not classified as low or high histologic grade
Micro images
=========================================================================
Various images

Low, intermediate and high power

Granular cytoplasm

Involving lobules

Forming tufts

Secretory features

Cells have abundant cytoplasm, vesicular nuclei and prominent nucleoli (AFIP)

Micropapillary pattern

Cribriform pattern

Androgen receptor staining
p53
Virtual slides
=========================================================================
Positive stains
=========================================================================
● Androgen receptor, B72.3 (92%, APMIS 2006;114:712),
ER-beta (73%,
Histopathology 2007;50:425)
● p53 (62%), HER2 (47%), Ki-67 (5% of cells)
(Mod Pathol 2000;13:13)
Negative stains
=========================================================================
● ER-alpha, PR, bcl2
Differential diagnosis
=========================================================================
● Atypical apocrine hyperplasia: difficult to distinguish from low-grade apocrine DCIS; absence of fully-developed architectural features of DCIS
Additional references
=========================================================================
● Hum Pathol 1994;25:164; Mod Pathol 1994;7:813; Stanford University
End of Breast malignant, males, children > In situ carcinoma > Apocrine DCIS
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).